Company attributes
B2X
Pitchbook URL
Number of Employees (Ranges)
51 – 2000
Email Address
partnerships@sonomabio.com0
media@sonomabio.com
info@sonomabio.com
Full Address
201 Haskins Way, Suite 203 South San Francisco, CA 94080, United States
410 W Harrison St, Suite 300 Seattle, WA 98119, United States
Investors
Total Funding Amount (USD)
340,000,000
Latest Funding Round Date
September 4, 2024
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
45,000,000
Sonoma Biotherapeutics is a privately held, San Francisco and Seattle-based company developing adoptive Treg therapies cell for autoimmune and degenerative diseases. Using genome editing and target-specific cell therapy, Sonoma is focused on developing the entire spectrum of Treg cell therapeutic capabilities. .
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
